About Brainomix
Brainomix is a global pioneer in AI medical imaging, specializing in software solutions designed to enable precision medicine and support physicians in making more confident, life-saving treatment decisions. Originating as a spin-out from the University of Oxford in 2010, the company has built a foundation of scientific excellence and a commitment to innovation. Their flagship product, Brainomix 360 Stroke, is a comprehensive AI-powered platform that streamlines stroke image analysis, providing real-time interpretation of brain scans. This technology assists clinicians in making rapid and accurate decisions regarding treatment and patient transfer, and has been clinically validated to significantly increase mechanical thrombectomy rates and improve functional independence for stroke patients.
Beyond its established success in stroke care, Brainomix is actively expanding its AI portfolio into other therapeutic areas characterized by significant unmet needs. These areas include various lung diseases, such as Interstitial Lung Disease (ILD) and Idiopathic Pulmonary Fibrosis (IPF), as well as oncology. For instance, their e-Lung platform leverages AI-driven CT biomarkers to identify, monitor, and predict disease progression in pulmonary fibrosis. The company’s overarching mission is to transform routine medical scans into actionable insights, thereby facilitating faster diagnoses, enhancing patient selection for therapies, and ultimately improving treatment outcomes across a broader spectrum of clinical pathways.
Focus Areas
Business Intelligence
| Key Investors | Parkwalk Advisors, Boehringer Ingelheim Venture Fund (BIVF), Hostplus (via IP Group Hostplus Innovation Fund), Modi Ventures, Tencent Holdings, Oxford University Innovation Fund (OUIF), LifeSci Capital |
| Partnerships | Medtronic Neurovascular (Western Europe), 3DR Labs (US), Pixyl (UK, Ireland, Nordics, Eastern Europe), West Virginia University (WVU) Health System, Angels Initiative, Stryker Neurovascular (EMEA), Wallaby Medical (China), Boehringer Ingelheim |
| Technology | AI-powered imaging platform (Brainomix 360 Stroke, e-Lung), automates validated imaging biomarkers, real-time interpretation of brain scans, state-of-the-art AI algorithms, cloud-native capabilities (e-Stroke Cloud Service), DICOM viewing, net water uptake (NWU) capability, e-ASPECTS, e-CTA, e-CTP, e-MRI, Triage Stroke, Triage LVO |
| FDA Clearances | 10+ cleared products (estimated) |
What Physicians Need to Know
Brainomix's AI-powered solutions offer physicians several critical advantages. The Brainomix 360 Stroke platform provides real-time, high-precision insights from various imaging modalities (NCCT, CTA, CTP, MRI) within 60 seconds, enabling faster and more accurate diagnosis and treatment decisions for stroke patients. This has been clinically proven to significantly increase mechanical thrombectomy rates and improve functional independence for stroke survivors. The platform's ability to unlock expert-level insights from universally available non-contrast CT scans is particularly valuable in centers without immediate access to advanced imaging or specialized neurologists. For lung fibrosis and cancer, their AI biomarkers support enhanced patient selection and efficacy assessment in clinical trials, streamlining research and potentially accelerating access to new treatments. The mobile app and cloud-based system facilitate seamless communication and data sharing across stroke networks, optimizing workflow and reducing critical door-in-door-out times.
Brainomix's solutions are designed for integration into existing radiology workflows and healthcare systems. The Brainomix 360 Stroke Mobile app, supported by the Brainomix 360 Cloud, allows for quick and secure access, review, and sharing of images and patient data across networks. The platform is FDA-cleared and CE-marked, indicating its compliance with regulatory standards for medical devices and software. Brainomix also focuses on value-generating partnerships to broaden its reach and deliver end-to-end solutions.
What the Web Says
Brainomix is generally well-regarded, particularly for its e-Stroke suite which receives positive feedback from healthcare professionals for its effectiveness in stroke management. As an employer, reviews are mixed but lean positive, with employees appreciating the company culture and meaningful work, though some concerns about management and workload exist.
Overall: PositiveStrengths
- e-Stroke suite significantly aids in stroke diagnosis and treatment decisions.
- Products are user-friendly and integrate well into clinical workflows.
- Positive impact on patient outcomes and clinical efficiency.
- Strong company culture and collaborative environment (employer reviews).
- Meaningful work in a growing field (employer reviews).
- Good work-life balance reported by some employees.
Limitations
- Some users report a learning curve with the software.
- Occasional technical glitches or support response times mentioned.
- Pricing can be a barrier for smaller institutions.
- Management communication and transparency issues cited by some employees.
- Workload can be demanding at times (employer reviews).
- Limited opportunities for career advancement for some roles.
Based on reviews from: G2, Glassdoor, Capterra, Healthcare IT News, Reddit
Last updated: 2026-07-17
Videos
News, demos, and interviews about Brainomix.
Videos load interactively. If none appear, search YouTube for Brainomix →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Brainomix.
Comparisons
Related Companies
Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]
TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]
Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]
Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]
Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]
Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]